|
|
||||||||
Ann Thorac Surg 2006;82:268-273
© 2006 The Society of Thoracic Surgeons
a Division of Thoracic Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
b Center for Clinical Effectiveness in Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
c Policy Analysis, Inc, Brookline, Massachusetts
Accepted for publication January 17, 2006.
* Address correspondence to Dr Gaissert, Massachusetts General Hospital, Blake 1570, 55 Fruit St, Boston, MA 02114 (Email: hgaissert{at}partners.org).
Presented at the Forty-second Annual Meeting of The Society of Thoracic Surgeons, Chicago, IL, Jan 30Feb 1, 2006.
BACKGROUND: Primary tracheal tumors other than adenoid cystic or squamous cell carcinoma are uncommon and have a heterogeneous histologic appearance. The experience regarding their treatment and long-term outcome is limited, and alternatives to segmental tracheal resection, including endoscopic treatment or radiation, continue to be explored.
METHODS: A retrospective analysis was performed of uncommon tracheal tumors among 360 primary tracheal tumors seen over 40 years, excluding adenoid cystic and squamous cell carcinoma.
RESULTS: Of 90 patients, 34 (38%) had benign tumors and 56 malignant: 11 carcinoid tumors, 14 mucoepidermoid carcinomas, 13 sarcomas, 15 nonsquamous bronchogenic carcinomas, 2 lymphomas, and 1 melanoma. Three patients had a second tracheal malignancy. Dyspnea was the most common symptom in benign tumors and hemoptysis in malignant tumors. Twelve patients did not undergo tracheal resection (13.3%) and 1 died before resection. Surgical therapy in 77 patients (85%) consisted of laryngectomy in 3, laryngotracheal resection in 9, tracheal resection in 46, and carinal resection in 19. Hospital mortality was 2.6% (2 of 77 patients) and major complications occurred in 16% (12 of 77 patients). Mean follow-up was 9.7 years. After resection, survival at 10 years was 94% for benign and 83% for carcinoid tumors, and at 5 years survival was 60% for bronchogenic carcinoma, 100% for mucoepidermoid tumors, and 78% for sarcomas. Patients with lymphomas and melanoma are alive more than 8 years after resection. Ten patients experienced recurrence (14%).
CONCLUSIONS: Surgical resection of uncommon primary tracheal tumors alleviates airway obstruction, is curative in patients with benign or slow-growing malignant lesions, and prolongs survival in highly malignant lesions.
This article has been cited by other articles:
![]() |
R. M. Terra, H. Minamoto, J. J.M. Junqueira, R. Falzoni, P. M. Pego-Fernandes, and F. B. Jatene Tracheal malignant melanoma: successful outcome with tracheal resection. Ann. Thorac. Surg., July 1, 2008; 86(1): 308 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
S JAIN, J P AGARWAL, T GUPTA, P M PARIKH, R C MISTRY, H MENON, C S PRAMESH, and S K SHRIVASTAVA Second primary small cell carcinoma of the trachea in a breast cancer survivor: a case report and literature review Br. J. Radiol., April 1, 2008; 81(964): e120 - e122. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Haver, C. J. Hartnick, D. P. Ryan, R. Shailam, and E. J. Mark Case 10-2008 -- A 10-Year-Old Girl with Dyspnea on Exertion N. Engl. J. Med., March 27, 2008; 358(13): 1382 - 1390. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |